BKT recommences drilling at Mahenge Graphite Project


Published 11-DEC-2017 12:19 P.M.


2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

Black Rock Mining (ASX:BKT) this morning announced that it has recommenced the Definitive Feasibility Study (DFS) for its 100%-owned Mahenge Graphite Project in Tanzania by drilling a metallurgical sample programme.

The drilling is set to begin immediately, with BKT having raised A$4.75 million in November to fund the programme. The planned metallurgical drilling and bulk sampling program at Ulanzi is due to be completed by January 2018 with the aim of improving confidence of consistently producing product to customer specification.

The programme is designed to define plant performance and product variability from the Ulanzi pit, via the bulk sampling of 500 tonnes for pilot plant testing in 2018.

Of course, as with all minerals exploration, success is not guaranteed – consider your own personal circumstances before investing, and seek professional financial advice.

BKT’s Executive Director and CEO John de Vries commented: “We are commencing the drilling and bulk sampling now as we want to ensure we complete it before the onset of the wet season. We are increasingly confident that we will see legislative clarification from the Tanzanian Government in the not too distant future, and are positioning the company to progress the Mahenge project to deliver a Definitive Feasibility Study in the second half of CY 2018.

“In commencing drilling we are voting with our feet and being proactive. We think Mahenge is the best undeveloped graphite project in the world, and we remain committed to developing it.”

BKT has one of the world’s largest flake graphite Resources at its Mahenge Project with a JORC compliant Mineral Resource Estimate of 211.9m tonnes at 7.8% TGC (total graphitic carbon) for 16.6m tonnes of contained Graphite, making this one of the largest JORC compliant flake graphite Mineral Resource Estimates in the world. Over half of the Mineral Resource is in the Measured and Indicated categories.

With a successful DFS and associated financing, construction could commence in 2018 with first production in late 2019.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.


Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free